PDF4PRO ⚡AMP

Modern search engine that looking for books and documents around the web

Example: barber

Appendix IV of the Guideline on the Investigation on ...

7 Westferry Circus Canary Wharf London E14 4HB United Kingdom Telephone +44 (0)20 7418 8400 Facsimile +44 (0)20 7418 8613 E-mail Website An agency of the European Union European Medicines Agency, 2011. Reproduction is authorised provided the source is acknowledged. 17 November 2011 EMA/CHMP/600958/2010/Corr.* Committee of Medicines for Human Use (CHMP) Appendix IV of the Guideline on the Investigation on Bioequivalence (CPMP/EWP/QWP/1401/98 ): Presentation of Biopharmaceutical and Bioanalytical Data in Module Draft agreed by Pharmacokinetics Working Party January 2011 Adoption by CHMP for release for consultation 17 February 2011 End of consultation (deadline for comments) 31 May 2011 Agreed by Pharmacokinetics Working Party November 2011 Adoption by CHMP 17 November 2011 Date for coming into effect 1 June 2012 Keywords Generic applications, bioequivalence data, BCS biowaiver documentation, Standardised presentation, CHMP, EMA, Guideline *The correction concerns clarifications/corrections in Tables and Appendix IV of the Guideline on the Investigation on Bioequivalence (CPMP/EWP/QWP/1401/98 ): Presentation of B

Appendix IV of the Guideline on the Investigation on Bioequivalence (CPMP/EWP/QWP/1401/98 Rev.1): Presentation of Biopharmaceutical and Bioanalytical Data in Module 2.7.1 Author

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam in document Broken preview Other abuse

Transcription of Appendix IV of the Guideline on the Investigation on ...

Related search queries